Vytrus Biotech has successfully registered the trademark for its Exopeptides™ technology — a strategic milestone in protecting the Spanish biotech company’s proprietary discoveries in natural plant exosomes and peptide science. The trademark covers the Exopeptides™ technology across three key active ingredients in the company’s portfolio: CLARIVINE™, CENTELLA REVERSA™, and CAPILIA LONGA™.
What Exopeptides™ Technology Covers
The Exopeptides™ trademark protects the unique combination of natural plant exosomes and bioactive peptide profiles that characterize these three actives. Plant exosomes — nano-sized extracellular vesicles derived from plant cell cultures — have emerged as a high-value delivery and signaling platform in cosmetic science, prized for their biological and clinical efficacy. The Exopeptides™ designation reflects Vytrus Biotech’s integrated approach: combining the exosome-rich secretome of totipotent plant cells with the bioactive peptide fractions that drive their skin and hair benefits. This builds on the company’s Phyto-Peptidic Fractions™ (PPF) platform, which has been the foundation of Vytrus’ plant-derived peptide research and biotechnology work published in Euro Cosmetics.
The Three Protected Actives
CLARIVINE™, CENTELLA REVERSA™, and CAPILIA LONGA™ are all built on the Exopeptides™ technology platform and are among the most commercially significant actives in Vytrus Biotech’s lineup. CENTELLA REVERSA™ is derived from Centella asiatica stem cells and is known for its senescence-reversal and skin rejuvenation properties. CAPILIA LONGA™, derived from Curcuma longa, targets hair growth and scalp biology. CLARIVINE™ addresses skin tone and clarity. All three are rich in plant exosomes and bioactive peptide profiles, attributes that are now collectively protected under the Exopeptides™ trademark.
Strategic IP Protection for a Growing Category
The trademark registration marks an important IP milestone for Vytrus Biotech, which has been a pioneer in plant cell culture-derived cosmetic actives since its founding as a spin-off from the Faculty of Pharmacy at the University of Barcelona. As the global demand for biotechnology-based actives grows — particularly in the premium skincare, anti-aging, and scalp care segments — the Exopeptides™ trademark positions Vytrus Biotech to protect and commercialize its technology more effectively across international markets.
For more information on Vytrus Biotech and the Exopeptides™ technology platform, visit Vytrus Biotech.
